BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16382342)

  • 1. Role of phosphate-activated glutaminase in the pathogenesis of hepatic encephalopathy.
    Romero-Gómez M
    Metab Brain Dis; 2005 Dec; 20(4):319-25. PubMed ID: 16382342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut ammonia production and its modulation.
    Romero-Gómez M; Jover M; Galán JJ; Ruiz A
    Metab Brain Dis; 2009 Mar; 24(1):147-57. PubMed ID: 19067141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy.
    Romero-Gómez M; Ramos-Guerrero R; Grande L; de Terán LC; Corpas R; Camacho I; Bautista JD
    J Hepatol; 2004 Jul; 41(1):49-54. PubMed ID: 15246207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives.
    Holecek M
    Metab Brain Dis; 2014 Mar; 29(1):9-17. PubMed ID: 23996300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis.
    Romero-Gomez M; Jover M; Diaz-Gomez D; de Teran LC; Rodrigo R; Camacho I; Echevarria M; Felipo V; Bautista JD
    World J Gastroenterol; 2006 Apr; 12(15):2406-11. PubMed ID: 16688834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
    Rose CF
    Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal.
    Albrecht J; Zielińska M; Norenberg MD
    Biochem Pharmacol; 2010 Nov; 80(9):1303-8. PubMed ID: 20654582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Minimal hepatic encephalopathy].
    Jover M; Hoyas E; Grande L; Romero-Gómez M
    Rev Gastroenterol Mex; 2009; 74(1):26-34. PubMed ID: 19666316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glutaminase activity and glutamine metabolism.
    Curthoys NP; Watford M
    Annu Rev Nutr; 1995; 15():133-59. PubMed ID: 8527215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ammonia neurotoxicity and the mitochondrial permeability transition.
    Norenberg MD; Rama Rao KV; Jayakumar AR
    J Bioenerg Biomembr; 2004 Aug; 36(4):303-7. PubMed ID: 15377862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of brain phosphate-activated glutaminase by ammonia and manganese.
    Rivera-Mancía S; Tristán-López L; Hernández-Díaz K; Rivera-Espinosa L; Ríos C; Montes S
    J Trace Elem Med Biol; 2020 Dec; 62():126625. PubMed ID: 32717575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.
    Wright G; Noiret L; Olde Damink SW; Jalan R
    Liver Int; 2011 Feb; 31(2):163-75. PubMed ID: 20673233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of hepatic encephalopathy and future treatment options.
    González-Regueiro JA; Higuera-de la Tijera MF; Moreno-Alcántar R; Torre A
    Rev Gastroenterol Mex (Engl Ed); 2019; 84(2):195-203. PubMed ID: 31014748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of glutamine in neurotransmission.
    Albrecht J; Sidoryk-Węgrzynowicz M; Zielińska M; Aschner M
    Neuron Glia Biol; 2010 Nov; 6(4):263-76. PubMed ID: 22018046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine-induced free radical production in cultured astrocytes.
    Jayakumar AR; Rama Rao KV; Schousboe A; Norenberg MD
    Glia; 2004 May; 46(3):296-301. PubMed ID: 15048852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian glutaminase isozymes in brain.
    Márquez J; Cardona C; Campos-Sandoval JA; Peñalver A; Tosina M; Matés JM; Martín-Rufián M
    Metab Brain Dis; 2013 Jun; 28(2):133-7. PubMed ID: 23149879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy.
    Thomas JW; Banner C; Whitman J; Mullen KD; Freese E
    Metab Brain Dis; 1988 Jun; 3(2):81-90. PubMed ID: 2903433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamine in the central nervous system: function and dysfunction.
    Albrecht J; Sonnewald U; Waagepetersen HS; Schousboe A
    Front Biosci; 2007 Jan; 12():332-43. PubMed ID: 17127302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THDP17 decreases ammonia production through glutaminase inhibition. A new drug for hepatic encephalopathy therapy.
    Díaz-Herrero MM; del Campo JA; Carbonero-Aguilar P; Vega-Pérez JM; Iglesias-Guerra F; Periñán I; Miñano FJ; Bautista J; Romero-Gómez M
    PLoS One; 2014; 9(10):e109787. PubMed ID: 25329718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.